A detailed history of Wt Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wt Wealth Management holds 6,080 shares of BMY stock, worth $360,361. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,080
Previous 6,080 -0.0%
Holding current value
$360,361
Previous $252,000 24.6%
% of portfolio
0.08%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$48.48 - $57.85 $31,511 - $37,602
650 Added 11.97%
6,080 $311,000
Q1 2023

Apr 19, 2023

BUY
$65.71 - $74.53 $356,805 - $404,697
5,430 New
5,430 $376,000
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $261,232 - $379,630
-5,630 Closed
0 $0
Q3 2019

Nov 06, 2019

BUY
$42.77 - $50.71 $240,795 - $285,497
5,630 New
5,630 $285,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wt Wealth Management Portfolio

Follow Wt Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wt Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Wt Wealth Management with notifications on news.